- 全部删除
您的购物车当前为空
TG6-129 是有效的EP2受体选择性拮抗剂,可降低 butaprost 诱导的 P388D1 巨噬细胞中炎症因子的表达。


为众多的药物研发团队赋能,
让新药发现更简单!
TG6-129 是有效的EP2受体选择性拮抗剂,可降低 butaprost 诱导的 P388D1 巨噬细胞中炎症因子的表达。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 997 | In stock | |
| 5 mg | ¥ 2,150 | In stock | |
| 10 mg | ¥ 3,870 | In stock | |
| 25 mg | ¥ 6,220 | In stock | |
| 50 mg | ¥ 8,550 | In stock | |
| 100 mg | ¥ 11,500 | In stock | |
| 500 mg | ¥ 22,800 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,850 | In stock |
TG6-129 相关产品
| 产品描述 | TG6-129 is an antagonist of the EP2 receptor. TG6-129 suppresses PGE2-induced elevation of cAMP in cells expressing EP2 with an IC50 value of 1.6 µM. TG6-129 reduces the expression of COX-2, IL-1β, IL-6, IL-12, IL-23 and TNF-α induced by the EP2-selective agonist butaprost in P388D1 macrophages. |
| 别名 | TG6 129 |
| 分子量 | 491.58 |
| 分子式 | C20H18FN5O3S3 |
| CAS No. | 1164464-14-5 |
| Smiles | CCC1=NN=C(NS(=O)(=O)C2=CC=C(NC(=S)NC(=O)\C=C\C3=CC=C(F)C=C3)C=C2)S1 |
| 密度 | 1.518 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 55 mg/mL (111.88 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容